Talecris Biotherapeutics Strengthens its Executive Leadership Team
Alberto Martinez, M.D. selected as new CEO, John Hanson becomes new CFO, and Mel Asbury named SVP, Human Resources
After a focused and methodical search, Talecris Biotherapeutics has completed its executive leadership team with the appointments of three experienced, highly regarded executives. Alberto Martinez, M.D., has assumed the position of President and Chief Executive Officer; John Hanson has assumed the position of Chief Financial Officer, and Mel Asbury has been named Senior Vice President of Human Resources.
Dr. Martinez joins Talecris from ZLB Behring, where he served as the Executive Vice President of Worldwide Commercial Operations. Mr. Hanson comes to Talecris from Andrx Corporation, having served there as CFO. Mr. Asbury will join Talecris in November after completing his current responsibilities with SpectraSite Communications. Larry Stern, who has served as the organization's Executive Chairman since its launch in April 2005, will continue as the Chairman of the Board of Directors, remaining an integral part of the Talecris business.
The news of Dr. Martinez, Mr. Hanson, and Mr. Asbury joining Talecris has been received positively by the patient communities served by Talecris.
Other news from the department people
